Skip to content
FunCoding

Search

Search docs, Skills and MCP

saas-valuation-compression

Analyze how a private SaaS company's ARR valuation multiple changed across funding rounds, and attribute the compression or expansion to rate cycles and macro selloffs, growth deceleration, narrative shifts (including an AI premium), competition, and investor demand, benchmarked against private-market medians and peers. Use this skill whenever the user asks about valuation compression, ARR multiples, round-to-round valuation or multiple changes, down rounds, or wants to compare a VC-backed software company's funding rounds. Research the rounds rather than answering from memory.

科研3.4kplugins/market-analysis/skills/saas-valuation-compression/SKILL.md

Install

Send this to Claude Code, Codex or Cursor. The agent checks the Skill for safety first and installs it only after you confirm.

读取 https://funcoding.ai/skills/himself65/finance-skills/saas-valuation-compression/install.md ,按里面的步骤帮我安装这个 Skill。

SKILL.md

SaaS Valuation Compression Analyzer

What This Skill Does

For a given SaaS company, research its funding history and compute ARR-based valuation multiples at each round. Then explain the compression (or expansion) using a structured framework that covers macro rates, growth trajectory, narrative shifts, and comparables.

Render the output as an inline visualization (using the Visualizer tool) plus a concise prose explanation, rather than a wall of numbers.


Workflow

Research these, running independent searches in parallel:

  • Each funding round of the target company — round name, date, amount raised, post-money valuation, and lead investor.
  • ARR at or near each round date — from press coverage, founder interviews, or investor posts; note when a figure is estimated.
  • Growth and retention around each round — ARR growth rate, NRR, churn, notable customers.
  • Narrative context — AI positioning and product launches, category leadership, competitive moves.
  • Private-market SaaS multiples at each round date — fall back on the dated tables in references/benchmarks.md when search is thin.

2. Build the Data Model

For each funding round, extract or estimate:

FieldHow to get it
Round nameDirect from search
DateDirect from search
Amount raisedDirect from search
Post-money valuationDirect or compute from ownership %; if unavailable, note as estimated
ARR at round dateSearch explicitly; if not found, estimate from customer count x ARPC or interpolate
ARR multiplevaluation / ARR
Lead investorDirect

ARR estimation heuristics (when not public):

  • Seed/Series A: ARR often $500K–$3M
  • Series B: typically $5M–$20M
  • Series C: typically $20M–$60M
  • Cross-check against customer count x average deal size if available

3. Compute Compression Metrics

For each consecutive round pair (e.g., B → C):

multiple_compression_pct = (later_multiple - earlier_multiple) / earlier_multiple × 100
valuation_growth_pct = (later_val - earlier_val) / earlier_val × 100
arr_growth_pct = (later_arr - earlier_arr) / earlier_arr × 100

The three changes multiply rather than add: valuation multiplier = ARR multiplier × multiple multiplier, i.e. (1 + valuation_growth) = (1 + arr_growth) × (1 + multiple_change). They are additive only in log terms, so use log changes wherever the decomposition needs to sum (for example, stacked bars). If ARR grows faster than the multiple compresses, absolute valuation still rises.

4. Attribute Compression to Causes

Use this checklist. For each cause, rate it: Primary / Contributing / Not applicable. references/benchmarks.md has dated private-market median multiples by period, public-software drawdowns, and known round-pair comparables for context.

Macro / Rate Environment

  • Was the earlier round priced during the 2020–2021 ZIRP bubble? (typically a ~2–5x artificial premium)
  • Was the later round priced during the 2022–2023 rate hikes? (removes the bubble premium)
  • Was the later round priced during or just after a sector-wide public-software selloff, such as the April 2026 meltdown? Private marks typically lag public ones by 1–2 quarters.
  • How does each round's multiple compare with the private-market median for its date?

Growth Deceleration

  • Did YoY ARR growth rate slow materially between rounds? (most common cause)
  • Did NRR/net retention drop?

Narrative Shift

  • Did the company lose a major product story (e.g., lost PLG thesis, missed category leadership)?
  • Did competitors emerge or incumbents catch up?

AI Premium (positive or negative)

  • Does the company serve AI-native companies (OpenAI, Anthropic, etc.) as customers? → premium
  • Did the company pivot to AI narrative credibly? → premium
  • Did the company fail to articulate AI story? → discount vs peers
  • In a macro-driven selloff an AI premium may be necessary but not sufficient — the April 2026 drawdowns in references/benchmarks.md show strong AI names falling with the sector.

Competitive / Market

  • Market saturation signal (e.g., Okta pressure on WorkOS, Auth0 competition)
  • Customer concentration risk revealed

Investor Supply / Demand

  • Was the later round smaller and more selective? → price discipline
  • New tier of lead investor (e.g., Tier 1 growth fund vs seed fund)? → may signal higher or lower conviction

5. Build the Visualization

Use the Visualizer tool to render:

  1. Metric cards row — valuation at each round, ARR at each round, multiple at each round, compression %
  2. Line chart — ARR multiple over time for the company vs macro SaaS median
  3. Bar chart — valuation growth vs ARR growth vs multiple change (decomposition, in log terms so the parts add up)
  4. Comparison bar — company compression vs 2–3 peer comparables (Vercel, Netlify, Fastly, or sector peers)
  5. Cause attribution table inline in prose (Primary / Contributing / N/A per factor)

See design guidance: use teal for positive/growth, coral for compression/negative, gray for macro baseline, blue for valuation figures. Follow the CSS variable system throughout.

6. Write the Prose Summary

Cover, in order:

  1. Verdict — one sentence, e.g., "The multiple compressed 36% but ARR grew 5x, so absolute valuation still rose about 3.2x."
  2. Primary cause — the #1 factor explaining compression
  3. Narrative premium/discount — AI story, category leadership, or lack thereof
  4. Comparable context — how this company's compression compares to peers
  5. Forward implication — what would need to be true for the multiple to expand at the next round

Output Format

Put the inline visualization first, followed by the prose summary. Flag your data confidence when ARR had to be estimated.


Edge Cases

  • Down round: Multiple and absolute valuation both dropped. Note dilution implications.
  • No public ARR: Use customer count x estimated ARPC, and label as estimate with +/- range.
  • Single round only: Compute multiple vs sector median for that date; can't do compression analysis. Explain this.
  • Pre-revenue: Use forward ARR or GMV multiple if applicable; note the different basis.
  • Acqui-hire / strategic acquisition: Acquisition price often reflects strategic premium or distress, not pure ARR multiple — flag this.

Reference Files

  • references/benchmarks.md — Dated private-market ARR multiples by period, April 2026 public SaaS drawdowns, and known round-pair comparables

Similar Skills

lead-research-assistant
ComposioHQ/awesome-claude-skills77k

lead-research-assistant

Identifies high-quality leads for your product or service by analyzing your business, searching for target companies, and providing actionable contact strategies. Perfect for sales, business development, and marketing professionals.

Science

13c-metabolic-flux
K-Dense-AI/scientific-agent-skills48k

13c-metabolic-flux

Estimates intracellular metabolic fluxes from steady-state carbon-13 isotope-tracing measurements using validated atom maps, mfapy isotope simulation, constrained multistart fitting, and flux-profile diagnostics. Use for 13C-MFA, carbon tracing, mass isotopomer distributions (MDVs/MIDs), positional isotopomers, parallel tracer experiments, and determining whether labeling data constrain a pathway flux. Distinguishes measured-label inference from COBRA flux balance analysis and flags experiments requiring nonstationary MFA.

Science

datamol
K-Dense-AI/scientific-agent-skills48k

datamol

Pythonic wrapper around RDKit with simplified interface and sensible defaults. Preferred for standard drug discovery including SMILES parsing, standardization, descriptors, fingerprints, clustering, 3D conformers, parallel processing. Returns native rdkit.Chem.Mol objects. For advanced control or custom parameters, use rdkit directly.

Science

biopython
K-Dense-AI/scientific-agent-skills48k

biopython

Provides Biopython workflows for sequence manipulation, file parsing (FASTA/GenBank/PDB), phylogenetics, and programmatic NCBI/PubMed access (Bio.Entrez). Supports batch processing, custom molecular-biology pipelines, BLAST automation, structure analysis, and motif analysis.

Science

bulk-rnaseq
K-Dense-AI/scientific-agent-skills48k

bulk-rnaseq

Prepares bulk RNA-seq FASTQ, Salmon, STAR or featureCounts output for gene-level differential expression. Covers nf-core/rnaseq and standalone quantification, biological replication, strandedness, reference provenance, validated count assembly and a PyDESeq2 handoff. Use for FASTQ-to-counts analysis, nf-core/rnaseq configuration, STAR/Salmon quantification, or building a counts matrix for DESeq2. For single-cell data use scanpy; for statistical fitting alone use pydeseq2.

Science

alphagenome
K-Dense-AI/scientific-agent-skills48k

alphagenome

Looks up precomputed AlphaGenome Atlas effects for any GRCh38 single-nucleotide variant (AVI score with Phred and 18 SHAP feature attributions, plus raw and quantile scores for RNA-seq, DNase, ATAC, ChIP-TF, ChIP-histone, CAGE, PRO-cap, splicing, polyadenylation and contact-map tracks), scores variants or scans windows on demand with the AlphaGenome model for human and mouse (variant scoring, in silico mutagenesis, REF-versus-ALT track prediction), and builds Atlas website deep links. Use when the user mentions AlphaGenome, AlphaGenome Atlas, AVI or AlphaGenome Variant Impact, DeepMind variant effect prediction, or wants to prioritise or mechanistically interpret non-coding, regulatory, splicing, enhancer, promoter, or chromatin-accessibility effects of SNVs from a VCF, credible set, or region. Research use only; not a clinical tool.

Science